CXM Stock Overview
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Chemed Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$565.00 |
| 52 Week High | US$605.00 |
| 52 Week Low | US$454.00 |
| Beta | 0.42 |
| 1 Month Change | -5.83% |
| 3 Month Change | 4.63% |
| 1 Year Change | 13.00% |
| 3 Year Change | 47.14% |
| 5 Year Change | 97.00% |
| Change since IPO | 2,835.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| CXM | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.9% | 2.7% | 0.5% |
| 1Y | 13.0% | -1.8% | 1.3% |
Return vs Industry: CXM exceeded the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: CXM exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| CXM volatility | |
|---|---|
| CXM Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CXM has not had significant price volatility in the past 3 months.
Volatility Over Time: CXM's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 15,087 | Kevin McNamara | www.chemed.com |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Chemed Corporation Fundamentals Summary
| CXM fundamental statistics | |
|---|---|
| Market cap | €8.72b |
| Earnings (TTM) | €264.19m |
| Revenue (TTM) | €2.14b |
30.6x
P/E Ratio3.8x
P/S RatioIs CXM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CXM income statement (TTM) | |
|---|---|
| Revenue | US$2.29b |
| Cost of Revenue | US$1.48b |
| Gross Profit | US$813.47m |
| Other Expenses | US$530.06m |
| Earnings | US$283.41m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 18.72 |
| Gross Margin | 35.47% |
| Net Profit Margin | 12.36% |
| Debt/Equity Ratio | 0% |
How did CXM perform over the long term?
See historical performance and comparison